Department of Neonatology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430070, China
Abstract:Objective To investigate the risk factors for the failure of ibuprofen treatment in preterm infants with hemodynamically significant patent ductus arteriosus (hsPDA). Methods A retrospective collection of clinical data was conducted on preterm infants with a gestational age of <34 weeks who were diagnosed with hsPDA and treated at the Department of Neonatology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, from January 2018 to June 2023. The subjects were divided into two groups based on the treatment approach: the ibuprofen group (95 cases) and the ibuprofen plus surgery group (44 cases). The risk factors for the failure of ibuprofen treatment in preterm infants with hsPDA were identified by binary logistic regression analysis. Results The binary logistic regression analysis revealed that an increased diameter of the ductus arteriosus, a resistance index (RI) value of the middle cerebral artery ≥0.80, and prolonged total invasive mechanical ventilation time were risk factors for the failure of ibuprofen treatment in preterm infants with hsPDA (P<0.05). Receiver operating characteristic curve analysis showed that a ductus arteriosus diameter >2.85 mm, a middle cerebral artery RI value ≥0.80, and a total invasive mechanical ventilation time >16 days had significant predictive value for the failure of ibuprofen treatment in preterm infants with hsPDA (P<0.05). The combined predictive value of these three factors was the highest, with an area under the curve of 0.843, a sensitivity of 86.5%, and a specificity of 75.0% (P<0.05). Conclusions A ductus arteriosus diameter >2.85 mm, a middle cerebral artery RI value ≥0.80, and a total invasive mechanical ventilation time >16 days are risk factors for the failure of ibuprofen treatment in preterm infants with hsPDA, and they are of significant predictive value for the necessity of surgical treatment following the failure of ibuprofen treatment.
WU Zi-Qi,ZHANG Yi,ZHOU Qian-Qian et al. Risk factors for the failure of ibuprofen treatment in preterm infants with hemodynamically significant patent ductus arteriosus[J]. CJCP, 2024, 26(4): 343-349.
Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus[J]. N Engl J Med, 2000, 343(10): 674-681. PMID: 10974130. DOI: 10.1056/NEJM200009073431001.
Lago P, Bettiol T, Salvadori S, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial[J]. Eur J Pediatr, 2002, 161(4): 202-207. PMID: 12014386. DOI: 10.1007/s00431-002-0915-y.
Lee JH, Lee HJ, Park HK, et al. Surgical ligation of patent ductus arteriosus in preterm neonates weighing less than 1500 g: a 9-year single center experience[J]. J Cardiothorac Surg, 2020, 15(1): 144. PMID: 32552772. PMCID: PMC7298442. DOI: 10.1186/s13019-020-01191-2.
Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants[J]. Cochrane Database Syst Rev, 2013, 2013(3): CD003951. PMID: 23543527. PMCID: PMC7027388. DOI: 10.1002/14651858.CD003951.pub3.
Edstedt Bonamy AK, Gudmundsdottir A, Maier RF, et al. Patent ductus arteriosus treatment in very preterm infants: a European population-based cohort study (EPICE) on variation and outcomes[J]. Neonatology, 2017, 111(4): 367-375. PMID: 28125815. DOI: 10.1159/000454798.
Toyoshima K, Isayama T, Kobayashi T, et al. What echocardiographic indices are predictive of patent ductus arteriosus surgical closure in early preterm infants? A prospective multicenter cohort study[J]. J Cardiol, 2019, 74(6): 512-518. PMID: 31256929. DOI: 10.1016/j.jjcc.2019.05.004.
Masutani S, Isayama T, Kobayashi T, et al. Ductus diameter and left pulmonary artery end-diastolic velocity at 3 days of age predict the future need for surgical closure of patent ductus arteriosus in preterm infants: a post-hoc analysis of a prospective multicenter study[J]. J Cardiol, 2021, 78(6): 487-492. PMID: 34481720. DOI: 10.1016/j.jjcc.2021.08.007.
Kwinta P, Rudziński A, Kruczek P, et al. Can early echocardiographic findings predict patent ductus arteriosus?[J]. Neonatology, 2009, 95(2): 141-148. PMID: 18776728. DOI: 10.1159/000153098.
Ecury-Goossen GM, Raets MM, Camfferman FA, et al. Resistive indices of cerebral arteries in very preterm infants: values throughout stay in the neonatal intensive care unit and impact of patent ductus arteriosus[J]. Pediatr Radiol, 2016, 46(9): 1291-1300. PMID: 27259991. PMCID: PMC4943974. DOI: 10.1007/s00247-016-3615-x.
Weir FJ, Ohlsson A, Myhr TL, et al. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity[J]. Eur J Pediatr, 1999, 158(6): 484-487. PMID: 10378397. DOI: 10.1007/s004310051125.
Camfferman FA, de Goederen R, Govaert P, et al. Diagnostic and predictive value of Doppler ultrasound for evaluation of the brain circulation in preterm infants: a systematic review[J]. Pediatr Res, 2020, 87(Suppl 1): 50-58. PMID: 32218536. PMCID: PMC7098887. DOI: 10.1038/s41390-020-0777-x.
Mashally S, Nield LE, McNamara PJ, et al. Late oral acetaminophen versus immediate surgical ligation in preterm infants with persistent large patent ductus arteriosus[J]. J Thorac Cardiovasc Surg, 2018, 156(5): 1937-1944. PMID: 30007780. DOI: 10.1016/j.jtcvs.2018.05.098.
Willis KA, Weems MF. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia[J]. Congenit Heart Dis, 2019, 14(1): 27-32. PMID: 30343505. DOI: 10.1111/chd.12691.